Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,052 | 167 | 99.6% |
| Education | $11.71 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $575.36 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $568.35 | 20 | $0 (2024) |
| Novo Nordisk Inc | $450.60 | 26 | $0 (2024) |
| PFIZER INC. | $362.52 | 26 | $0 (2024) |
| Lilly USA, LLC | $288.46 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $117.69 | 7 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $78.27 | 4 | $0 (2024) |
| Abbott Laboratories | $72.77 | 4 | $0 (2024) |
| Amgen Inc. | $67.50 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $63.71 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $826.12 | 46 | PFIZER INC. ($177.67) |
| 2023 | $979.33 | 58 | Novo Nordisk Inc ($169.03) |
| 2022 | $740.10 | 28 | AstraZeneca Pharmaceuticals LP ($316.67) |
| 2021 | $517.81 | 36 | AbbVie Inc. ($167.55) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Biological | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Gastroenterology | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: PAIN | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Gastroenterology | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: DIABETES | ||||||
| 08/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: PAIN | ||||||
| 07/23/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: PAIN | ||||||
| 07/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Oncology | ||||||
| 06/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: PAIN | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 448 | 700 | $153,367 | $49,333 |
| 2022 | 6 | 395 | 588 | $130,530 | $40,647 |
| 2021 | 8 | 490 | 710 | $150,774 | $49,016 |
| 2020 | 6 | 328 | 474 | $86,365 | $25,220 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 488 | $104,432 | $31,421 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 71 | 71 | $16,401 | $7,221 | 44.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 29 | $11,165 | $5,032 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 64 | $11,200 | $2,959 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,944 | $2,238 | 28.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 13 | $1,950 | $424.06 | 21.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 11 | $275.00 | $37.51 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 256 | 442 | $94,588 | $28,030 | 29.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 50 | 50 | $11,550 | $5,253 | 45.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 13 | $5,005 | $2,174 | 43.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $7,282 | $1,779 | 24.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 13 | $3,705 | $1,722 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 48 | $8,400 | $1,690 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 217 | 374 | $80,036 | $26,374 | 33.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 134 | 192 | $33,600 | $9,266 | 27.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 46 | 46 | $10,626 | $5,155 | 48.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 41 | 41 | $13,571 | $2,946 | 21.7% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 13 | 14 | $5,390 | $2,519 | 46.7% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 14 | 16 | $4,560 | $2,221 | 48.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,616 | $483.30 | 18.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 13 | 15 | $375.00 | $52.20 | 13.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 111 | 179 | $38,306 | $12,019 | 31.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 155 | 233 | $33,965 | $8,870 | 26.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $7,944 | $2,470 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 14 | 14 | $3,234 | $1,369 | 42.3% |
About Brandon Still, APRN
Brandon Still, APRN is a Family healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/10/2018. The National Provider Identifier (NPI) number assigned to this provider is 1215408604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brandon Still, APRN has received a total of $3,063 in payments from pharmaceutical and medical device companies, with $826.12 received in 2024. These payments were reported across 168 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,052).
As a Medicare-enrolled provider, Still has provided services to 1,661 Medicare beneficiaries, totaling 2,472 services with total Medicare billing of $164,216. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Clermont, FL
- Active Since 12/10/2018
- Last Updated 12/10/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215408604
Products in Payments
- FARXIGA (Drug) $463.60
- QULIPTA (Drug) $305.38
- Ozempic (Drug) $296.35
- NURTEC ODT (Drug) $281.85
- UBRELVY (Drug) $222.88
- MOUNJARO (Drug) $153.02
- Rybelsus (Drug) $118.21
- XARELTO (Drug) $117.69
- PREVNAR 20 (Biological) $95.01
- JARDIANCE (Drug) $88.51
- XIFAXAN (Drug) $78.27
- BREZTRI (Drug) $72.94
- Otezla (Drug) $67.50
- FREESTYLE LIBRE 2 (Device) $57.86
- Cologuard Collection Kit (Device) $54.43
- BELSOMRA (Drug) $47.29
- VRAYLAR (Drug) $47.10
- Vascepa (Drug) $45.96
- Wegovy (Drug) $36.04
- ELIQUIS (Drug) $35.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Clermont
Mrs. Chantal Baptiste, Aprn, APRN
Family — Payments: $13,695
Ashlee Koronka, Aprn, APRN
Family — Payments: $7,969
Jessica Bean, Arnp, ARNP
Family — Payments: $5,976
Mrs. Narissa Seelall, Aprn, APRN
Family — Payments: $5,676
Tammy Covington, Np-C, NP-C
Family — Payments: $5,500
Chelsea Merrow, Aprn, APRN
Family — Payments: $5,044